ARG-Vasopressin inhibitors belong to a specific class of chemical compounds that have garnered attention in the field of neuroendocrinology and peptide hormone regulation. Arginine Vasopressin (AVP), also known as antidiuretic hormone, is a neuropeptide produced by the hypothalamus and released from the posterior pituitary gland in response to various physiological cues, such as changes in blood osmolarity and blood pressure. AVP plays a critical role in regulating water balance, blood pressure, and vascular tone by acting on specific receptors in the kidneys, blood vessels, and other target tissues. The inhibition of AVP activity can have profound effects on fluid homeostasis and cardiovascular regulation, making AVP inhibitors important tools for studying AVP's physiological roles and its impact on various organ systems.
The mechanism of action of ARG-Vasopressin inhibitors typically involves their interaction with AVP or its receptors, interfering with AVP binding or signaling pathways. This interaction can lead to changes in AVP's ability to modulate water reabsorption in the kidneys, vasoconstriction, and other physiological responses. Consequently, ARG-Vasopressin inhibitors may have implications for understanding the regulatory mechanisms governing fluid and electrolyte balance, blood pressure regulation, and the pathophysiology of conditions related to AVP dysregulation. These inhibitors provide valuable tools for investigating AVP's role in health and disease, shedding light on the complex network of hormonal and neural signals that control vital physiological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $61.00 | 17 | |
Acts as a glucocorticoid receptor antagonist, which may decrease CRH release and subsequently AVP expression. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Inhibits steroidogenesis, potentially reducing corticosteroid levels, which could indirectly affect AVP synthesis. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Can affect renal response to AVP and indirectly influence its secretion and synthesis. | ||||||
Clomipramine hydrochloride | 17321-77-6 | sc-203898 | 1 g | $38.00 | 2 | |
A compound that may affect hypothalamic neurons and potentially AVP synthesis. | ||||||
Captopril | 62571-86-2 | sc-200566 sc-200566A | 1 g 5 g | $49.00 $91.00 | 21 | |
An ACE inhibitor that could alter blood pressure regulation and indirectly affect AVP release. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
As an angiotensin receptor blocker, it may influence the regulation of AVP secretion. | ||||||
Levodopa | 59-92-7 | sc-205372 sc-205372A | 5 g 25 g | $54.00 $171.00 | 9 | |
May modulate central neurotransmitter pathways influencing AVP expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A synthetic glucocorticoid that can suppress CRH and potentially reduce AVP gene expression. | ||||||